Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 08/01/2025 | PUT | $61.00 | 631 | +486 | +335.17% |
| 08/15/2025 | CALL | $90.00 | 5,491 | +377 | +7.37% |
| 08/15/2025 | PUT | $55.00 | 4,027 | +369 | +10.09% |
| 08/01/2025 | CALL | $67.00 | 682 | +354 | +107.93% |
| 03/20/2026 | PUT | $55.00 | 3,519 | +327 | +10.24% |
| 07/25/2025 | CALL | $69.00 | 914 | +309 | +51.07% |
| 01/16/2026 | PUT | $55.00 | 8,003 | -53 | -0.66% |
| 08/01/2025 | CALL | $66.00 | 382 | -90 | -19.07% |
| 08/15/2025 | CALL | $80.00 | 9,212 | -96 | -1.03% |
| 08/15/2025 | PUT | $65.00 | 5,920 | -99 | -1.64% |
| 07/25/2025 | CALL | $68.00 | 1,280 | -116 | -8.31% |
| 08/15/2025 | CALL | $60.00 | 1,035 | -120 | -10.39% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Harbor Capital Appreciation Fund | 0.18% | 3.11M | 481.53M |
| Washington Mutual Investors Fund | 0.09% | 1.51M | 234.45M |
| Vanguard U.S. Growth Fund | 0.07% | 1.27M | 196.47M |
| Loomis Sayles Growth Fund | 0.07% | 1.18M | 183.13M |
| Fidelity Blue Chip Growth Fund | 0.07% | 1.13M | 175.35M |
| Amana Mutual Funds Trust-Growth Fund | 0.06% | 1M | 155.09M |
| PGIM Jennison Growth Fd | 0.05% | 828.11k | 128.15M |
| Blackrock Equity Dividend Fund | 0.04% | 712k | 110.18M |
| New Perspective Fund Inc | 0.04% | 691.44k | 107M |
| Price (T.Rowe) International Stock Fund | 0.04% | 674k | 104.3M |
HIMS Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of August 25, 2025 Deadline in Securities Fraud Class Action Lawsuit Against Hims & Hers Health, Inc. (HIMS)
07/23 10:52 am
GlobeNewswire Inc.
Read moreHims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights
07/21 02:41 pm
GlobeNewswire Inc.
Read more2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade
07/21 08:15 am
The Motley Fool
Read moreNodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer
07/21 07:00 am
GlobeNewswire Inc.
Read moreA Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money
07/20 09:24 pm
The Motley Fool
Read moreHIMS SECURITIES NEWS: Did Hims & Hers Health, Inc. (NYSE:HIMS) Commit Securities Fraud? Contact BFA Law by August 25 Class Action Deadline
07/20 07:06 am
GlobeNewswire Inc.
Read moreROSEN, LEADING TRIAL ATTORNEYS, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
07/19 05:19 pm
GlobeNewswire Inc.
Read moreAfter Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
07/19 06:09 am
The Motley Fool
Read moreHIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
07/17 04:00 pm
GlobeNewswire Inc.
Read moreHims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights
07/16 04:50 pm
GlobeNewswire Inc.
Read more3 Absurdly Cheap Growth Stocks to Load Up On Right Now
07/15 03:33 am
The Motley Fool
Read moreGLP-1 Agonists Drug Pipeline Analysis Market Report 2025 | Next-generation GLP-1 Agonists Pave the Way for Diabetes and Obesity Management
07/14 05:56 am
GlobeNewswire Inc.
Read moreROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
07/11 02:45 pm
GlobeNewswire Inc.
Read moreROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
07/10 08:57 pm
GlobeNewswire Inc.
Read more3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly
07/09 06:16 pm
The Motley Fool
Read moreAlzheimer’s Therapeutics Market on Upward Trajectory Across the 7MM During the Forecast Period (2025–2034) Fueled by Drug Development Advances | DelveInsight
07/08 01:00 pm
GlobeNewswire Inc.
Read more$1,000 in VEA Could Turn Into $57,000
07/08 06:11 am
The Motley Fool
Read moreROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
07/07 07:23 pm
GlobeNewswire Inc.
Read moreINVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HIMS
07/07 02:05 pm
GlobeNewswire Inc.
Read moreDeadline Alert: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
07/07 12:00 pm
GlobeNewswire Inc.
Read moreHIMS Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges HIMS Investors with Losses to Contact the Firm
07/06 01:17 pm
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
07/06 10:00 am
GlobeNewswire Inc.
Read moreWhy I Think Viking Therapeutics Is an Asymmetric Growth Opportunity
07/04 04:30 am
The Motley Fool
Read moreRobbins LLP Urges HIMS Stockholders with Large Losses to Contact the Firm for Information About the Class Action Pending Against Hims & Hers Health, Inc.
07/03 07:41 pm
GlobeNewswire Inc.
Read moreINVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims & Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
07/01 07:49 pm
GlobeNewswire Inc.
Read moreHIMS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. and Encourages Investors to Contact the Firm
06/30 09:00 pm
GlobeNewswire Inc.
Read moreROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
06/30 05:45 pm
GlobeNewswire Inc.
Read moreINVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
06/29 03:05 pm
GlobeNewswire Inc.
Read moreBREAKING HIMS NEWS: A Securities Fraud Class Action has been Filed on behalf of Hims & Hers Health, Inc. (NYSE:HIMS) Investors -- Contact BFA Law if You Lost Money
06/28 07:46 am
GlobeNewswire Inc.
Read moreHims & Hers Stock Financial Analysis Following Huge Stock Price Crash
06/28 07:30 am
The Motley Fool
Read moreHIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
06/27 04:00 pm
GlobeNewswire Inc.
Read moreMassive News for Hims & Hers Stock Investors!
06/27 04:02 am
The Motley Fool
Read moreGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (HIMS)
06/26 02:46 pm
GlobeNewswire Inc.
Read moreHIMS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Hims & Hers Class Action Lawsuit
06/25 09:19 pm
GlobeNewswire Inc.
Read more3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
06/25 06:05 am
The Motley Fool
Read moreUnited States Insulin Pens Market Research Report 2025-2033, Advances in Technology, Favorable Reimbursement Policies, Increasing Awareness and Adoption
06/25 05:56 am
GlobeNewswire Inc.
Read moreWhy Did Hims and Hers Stock Crash on Monday?
06/24 06:30 am
The Motley Fool
Read moreNovo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
06/22 03:35 pm
GlobeNewswire Inc.
Read moreNovo Nordisk: Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA
06/20 07:38 pm
GlobeNewswire Inc.
Read more